Enhancement of chemotherapy by manipulation of tumour pH

被引:261
作者
Raghunand, N
He, X
van Sluis, R
Mahoney, B
Baggett, B
Taylor, CW
Paine-Murrieta, G
Roe, D
Bhujwalla, ZM
Gillies, RJ
机构
[1] Arizona Canc Ctr, Tucson, AZ 85724 USA
[2] Johns Hopkins Sch Med, Dept Radiol, Baltimore, MD USA
关键词
doxorubicin; acid-base balance; chemotherapy; MRS; bicarbonate;
D O I
10.1038/sj.bjc.6690455
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The extracellular (interstitial) pH (pHe) of solid tumours is significantly more acidic compared to normal tissues. in-vitro, low pH reduces the uptake of weakly basic chemotherapeutic drugs and, hence, reduces their cytotoxicity. This phenomenon has been postulated to contribute to a 'physiological' resistance to weakly basic drugs in vivo. Doxorubicin is a weak base chemotherapeutic agent that is commonly used in combination chemotherapy to clinically treat breast cancers. This report demonstrates that MCF-7 human breast cancer cells in vitro are more susceptible to doxorubicin toxicity at pH 7.4, compared to pH 6.8. Furthermore P-31-magnetic resonance spectroscopy (MRS) has shown that the pHe of MCF-7 human breast cancer xenografts can be effectively and significantly raised with sodium bicarbonate in drinking water. The bicarbonate-induced extracellular alkalinization leads to significant improvements in the therapeutic effectiveness of doxorubicin against MCF-7 xenografts in vivo. Although physiological resistance to weakly basic chemotherapeutics is well-documented in vitro and in theory, these data represent the first in vivo demonstration of this important phenomenon.
引用
收藏
页码:1005 / 1011
页数:7
相关论文
共 26 条
[1]   Defective acidification in human breast tumor cells and implications for chemotherapy [J].
Altan, N ;
Chen, Y ;
Schindler, M ;
Simon, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10) :1583-1598
[2]   High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes [J].
Bearman, SI ;
Overmoyer, BA ;
Bolwell, BJ ;
Taylor, CW ;
Shpall, EJ ;
Cagnoni, PJ ;
Mechling, BE ;
Ronk, B ;
Baron, AE ;
Purdy, MH ;
Ross, M ;
Jones, RB .
BONE MARROW TRANSPLANTATION, 1997, 20 (11) :931-937
[3]  
Cesano A, 1997, ANTICANCER RES, V17, P1887
[4]  
CORBETT TH, 1982, CANCER TREAT REP, V66, P1187
[5]   Tumour blood flow influences combined radiation and doxorubicin treatments [J].
Durand, RE ;
LePard, NE .
RADIOTHERAPY AND ONCOLOGY, 1997, 42 (02) :171-179
[6]   DETERMINATION OF CELL NUMBER IN MONOLAYER-CULTURES [J].
GILLIES, RJ ;
DIDIER, N ;
DENTON, M .
ANALYTICAL BIOCHEMISTRY, 1986, 159 (01) :109-113
[7]  
GILLIES RJ, 1994, AM J PHYSIOL, P195
[8]  
GILLIES RJ, 1978, CURR TOP BIOENERG, V9, P63
[9]   ARE CANCER-CELLS ACIDIC [J].
GRIFFITHS, JR .
BRITISH JOURNAL OF CANCER, 1991, 64 (03) :425-427
[10]   Cure of multidrug-resistant human B-cell lymphoma xenografts by combinations of anti-B4-blocked ricin and chemotherapeutic drugs [J].
Liu, CN ;
Lambert, JM ;
Teicher, BA ;
Blattler, WA ;
OConnor, R .
BLOOD, 1996, 87 (09) :3892-3898